XSHE
002919
Market cap656mUSD
Oct 09, Last price
16.32CNY
1D
-1.09%
1Q
-14.33%
IPO
123.87%
Name
MINGCHEN HEALTH Co Ltd
Chart & performance
P/E
153.43
P/S
2.87
EPS
0.11
Div yield, %
0.30%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
15.27%
Revenues
1.51b
+9.72%
Net income
28m
-39.41%
CFO
88m
-46.97%
Dividend
Jun 09, 20260.05 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1994 and headquartered in Shantou, China, Mingchen Health Co., Ltd. is a key player in the Chinese personal care sector. The company's core activities involve the research, manufacturing, and distribution of a variety of personal health and hygiene products. Its offerings notably include hair care solutions such as anti-dandruff shampoos and conditioners, as well as an assortment of skincare lotions. These items are sold under a portfolio of brands, including Did Flower Show, MeiWang, YiCai, High-tech Health, Green effect, and Likoujian. The company was formerly known as Guangdong Ming Chen Co., Ltd. before its current rebranding.
Key people
Jianming Chen
Chairman of the Board, General Manager · since 2021
Dongsong Chen
Deputy General Manager, Secretary of the Board, Director · since 2021
Jinhui Liang
Director · since 2024
Xiaoqing Peng
Vice Chairman of the Board, Chief Financial Officer, Deputy General Manager · since 2021
Jinghua Chen
Independent Director · since 2024
Hui Gao
Independent Director · since 2021
Xiaoyan Wu
Independent Director · since 2021
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||